120 related articles for article (PubMed ID: 1917520)
1. Suitability of rodent tumor models for experimental PET with L-[1-11C]tyrosine and 2-[18F]fluoro-2-deoxy-D-glucose.
Daemen BJ; Elsinga PH; Paans AM; Lemstra W; Konings AW; Vaalburg W
Int J Rad Appl Instrum B; 1991; 18(5):503-11. PubMed ID: 1917520
[TBL] [Abstract][Full Text] [Related]
2. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
[TBL] [Abstract][Full Text] [Related]
3. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
[TBL] [Abstract][Full Text] [Related]
4. Comparative double-tracer whole-body autoradiography: uptake of 11C-, 18F- and 3H-labeled compounds in rat tumors.
d'Argy R; Paul R; Frankenberg L; Stålnacke CG; Lundqvist H; Kangas L; Halldin C; Någren K; Roeda D; Haaparanta M
Int J Rad Appl Instrum B; 1988; 15(5):577-85. PubMed ID: 2978293
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for monitoring the response of tumors to radiotherapy in mice.
Murayama C; Harada N; Kakiuchi T; Fukumoto D; Kamijo A; Kawaguchi AT; Tsukada H
J Nucl Med; 2009 Feb; 50(2):290-5. PubMed ID: 19164228
[TBL] [Abstract][Full Text] [Related]
6. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.
Leskinen-Kallio S; Ruotsalainen U; Någren K; Teräs M; Joensuu H
J Nucl Med; 1991 Jun; 32(6):1211-8. PubMed ID: 2045935
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced inhibition of tumor growth as monitored by PET using L-[1-11C]tyrosine and fluorine-18-fluorodeoxyglucose.
Daemen BJ; Elsinga PH; Paans AM; Wieringa AR; Konings AW; Vaalburg W
J Nucl Med; 1992 Mar; 33(3):373-9. PubMed ID: 1740705
[TBL] [Abstract][Full Text] [Related]
8. A comparative PET study using different 11C-labelled amino acids in Walker 256 carcinosarcoma-bearing rats.
Daemen BJ; Elsinga PH; Ishiwata K; Paans AM; Vaalburg W
Int J Rad Appl Instrum B; 1991; 18(2):197-204. PubMed ID: 2026496
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.
Kubota R; Yamada S; Kubota K; Ishiwata K; Tamahashi N; Ido T
J Nucl Med; 1992 Nov; 33(11):1972-80. PubMed ID: 1432158
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study for tumor detection using 18F-2-fluoro-deoxy-D-glucose: imaging of rabbit VX2-tumor with single photon gamma camera].
Abe Y; Matsuzawa T; Fukuda H; Endo S; Yamada K; Sato T; Ito M; Kubota K; Hatazawa J; Yoshioka S
Kaku Igaku; 1985 Mar; 22(3):389-91. PubMed ID: 3874982
[No Abstract] [Full Text] [Related]
11. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.
Reinhardt MJ; Kubota K; Yamada S; Iwata R; Yaegashi H
J Nucl Med; 1997 Feb; 38(2):280-7. PubMed ID: 9025756
[TBL] [Abstract][Full Text] [Related]
12. Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.
Kole AC; Nieweg OE; Pruim J; Paans AM; Plukker JT; Hoekstra HJ; Schraffordt Koops H; Vaalburg W
J Nucl Med; 1997 May; 38(5):692-6. PubMed ID: 9170429
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
14. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
Fukuda H; Matsuzawa T; Abe Y; Endo S; Yamada K; Kubota K; Hatazawa J; Sato T; Ito M; Takahashi T; Iwata R; Ido T
Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
[TBL] [Abstract][Full Text] [Related]
15. An animal model for in vivo evaluation of tumor glycolytic rates with positron emission tomography.
Hawkins RA; Choi Y; Scates S; Rege S; Hoh CK; Glaspy J; Phelps ME
J Surg Oncol; 1993 Jun; 53(2):104-9. PubMed ID: 8501902
[TBL] [Abstract][Full Text] [Related]
16. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes.
Wahl RL; Kaminski MS; Ethier SP; Hutchins GD
J Nucl Med; 1990 Nov; 31(11):1831-5. PubMed ID: 2230996
[TBL] [Abstract][Full Text] [Related]
17. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
[TBL] [Abstract][Full Text] [Related]
18. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography.
Wahl RL; Hutchins GD; Buchsbaum DJ; Liebert M; Grossman HB; Fisher S
Cancer; 1991 Mar; 67(6):1544-50. PubMed ID: 2001543
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent.
Inoue T; Tomiyoshi K; Higuichi T; Ahmed K; Sarwar M; Aoyagi K; Amano S; Alyafei S; Zhang H; Endo K
J Nucl Med; 1998 Apr; 39(4):663-7. PubMed ID: 9544678
[TBL] [Abstract][Full Text] [Related]
20. PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline.
Salem N; Kuang Y; Wang F; Maclennan GT; Lee Z
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):144-56. PubMed ID: 19039303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
